Belgium: Gimv raises €247m from rights issue
Belgium-based private equity firm, Gimv, has completed the first phase of its rights issue resulting in a take-up of 82.5% of the new shares. An accelerated...
Switzerland: BioVersys shares begin trading on SIX Swiss
BioVersys, a Switzerland-based multi-asset, clinical stage biopharmaceutical company focusing on R&D of novel antibacterial products, has priced its IPO at CHF36 per share, implying...
Germany: Lauxera invests in German neurovascular medical device company
France-based international healthcare-focused asset management company Lauxera Capital Partners has invested in Acandis, a German neurovascular medical device company dedicated to the prevention and...
Sweden: Safe Life adds to portfolio with acquisition of Life Safety Solutions
Safe Life, a Stockholm-based provider of life-saving solutions with portfolio companies across Europe and North America, has acquired US-based Life Safety Solutions, a provider of life safety equipment...
France: Proteor expands digital solutions with Filament Innovations
Proteor, a France-based developer of prostheses, orthoses, orthopedic components and application software, has acquired Filament Innovations, a US-based designer and manufacturer of 3D printing...
UK: Liva Healthcare acquires Discover Momenta and secures new backing
Liva Healthcare, a digital health technology platform delivering best-in-class outcomes for lifestyle-related chronic diseases, has acquired UK-based Discover Momenta, including subsidiary Momenta Newcastle, for...
UK: Asker Healthcare acquires HSL from Foresight
Asker Healthcare Group, a Sweden-based provider of medical products and solutions has acquired Northern Ireland-based Hospital Services Limited (HSL), alongside HSL management, from Foresight...
Poland: MidEuropa raises over US$400m from Diagnostyka IPO
Diagnostyka, a provider of diagnostic services with the largest network of medical laboratories and blood collection points in Poland, has priced its all secondary...
Australia: AdvanCell completes oversubscribed US$112m Series C
Australia-based clinical-stage radiopharmaceutical company, AdvanCell, a developer of cancer therapeutics, has completed an oversubscribed US$112m Series C financing.
The funding round was co-led by SV...
UK: Knight Frank advises on sale of UK care home portfolio [update]
Knight Frank’s Healthcare team has advised North Bay Group on the sale of a portfolio of six care homes across the North of England...













![UK: Knight Frank advises on sale of UK care home portfolio [update]](https://www.investorsinhealthcare.com/wp-content/uploads/2024/11/elderly-care-218x150.jpg)


